Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients.

O Lukkarinen, GL Hammond, M Kontturi… - Investigative …, 1980 - europepmc.org
The long-term effects of endocrine therapy, including polyestradiol phosphate (Estradurin)
administration, castration, and their combination, on the circulating concentrations of …

Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone

FR Ahmann, ED Crawford, W Kreis, Y Levasseur… - Cancer research, 1987 - AACR
Monthly serum dehydroepiandrosterone sulfate, androstenedione, testosterone,
dihydrotestosterone, and free testosterone levels were measured in 94 of 129 patients with …

Testicular steroid secretion and peripheral serum steroid concentrations in patients with prostatic carcinoma after short-term estrogen treatment.

O Lukkarinen, GL Hammond, M Kontturi… - Investigative …, 1979 - europepmc.org
The short-term effects of the administration of estradiol on testicular steroid production were
assessed by measuring the serum concentrations of testosterone, and a number of its …

Hormone Changes in Patients with Prostatic Carcinoma, During Treatment with Estramustine Phosphate

SD Fosså, J Fosså, A Aakvaag - The Journal of Urology, 1977 - Elsevier
Hormone analyses of plasma were done on 9 patients with prostatic carcinoma before,
during and after treatment with estramustine phosphate. In previously untreated men …

Steroids in reactivated prostatic cancer

H Brendler - Methods in hormone research, 1965 - books.google.com
Primary androgen-control measures elicit a favorable response in most patients with
advanced prostatic cancer. At least 20%, however, fail to regress; the remainder ultimately …

ESTRADURIN®(POLYOESTRADIOL PHOSPHATE IN THE TREATMENT OF PROSTATIC CARCINOMA. A CLINICAL AND STEROID METABOLIC STUDY

G Jönsson, E Diczfalusy, LO Plantin… - European Journal of …, 1963 - academic.oup.com
ABSTRACT A series of 105 cases of histologically verified prostatic carcinoma were treated
with monthly doses of 80–200 mg of Estradurin (polyoestradiol phosphate). The series were …

Evaluation of relationship between corticosteroid-induced adrenocortical suppression and clinical effectiveness of corticosteroid therapy in prostatic carcinoma

SD Weinert, LJ Marks, R Chute, JB Dowd - The Journal of Urology, 1960 - auajournals.org
MATERIALS AND METHODS Ten patients, with carcinoma of the prostate, varying in age
from 55 to 79 years, were selected for this study. Each patient had undergone bilateral …

Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine

MC Bishop, C Selby, M Taylor - British journal of urology, 1985 - Wiley Online Library
Plasma testosterone, oestradiol, luteinising hormone (LH) growth hormone and prolactin
were measured serially in 140 patients with advanced prostatic carcinoma (T3, T4, MI and …

Hormonal therapy in prostatic carcinoma.

MI Resnick - Urology, 1984 - europepmc.org
A significant number of patients with newly diagnosed prostatic cancer will be found to have
metastatic disease at time of presentation. Since the work of Huggins and Hodges in the …

A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy

K Carlström, L Collste, A Eriksson, P Henriksson… - The …, 1989 - Wiley Online Library
The effects of orchidectomy, combined oral/parenteral estrogen, and single‐drug parenteral
estrogen therapy on the serum levels of testosterone (T), 4‐androstene‐3, 17‐dione (A‐4) …